Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy

We here describe a patient with an idiopathic thrombotic thrombocytopenic purpura (TTP) secondary to an ADAMTS13 inhibitor that continued to be dependent on plasmapheresis until the patient was treated with rituximab. TTP manifestations subsided with rituximab treatment in spite of a persistently lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Musa, Faisal, Baidas, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: April, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448046/
https://www.ncbi.nlm.nih.gov/pubmed/26034479
http://dx.doi.org/10.1159/000381868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448046/
https://www.ncbi.nlm.nih.gov/pubmed/26034479
http://dx.doi.org/10.1159/000381868

Ejemplares similares